Improving General Fertility Rate Steers Sales of Pregnancy Products Worldwide, says TMR The top three players leading the U.S. pregnancy product market collectively hold a share of 25% in the overall market, Transparency Market Research (TMR) finds. The largest share of about 10% is held by Expanscience Laboratories, Inc. Its leading brands, Mustela and Piascledine 300, are spread over 97 countries, garnering a remarkable presence and indomitable revenues. Currently, Expanscience Laboratories, Inc. has 808 patents registered around the world, which will give it a competitive advantage over others in the foreseeable future. E.T Browne Drug Co., Inc. is the next big contender in the overall market with a share of about 8.1%. The unique ingredients used to make effective line of products and the usage of cocoa butter to enhance the quality of products are giving this company the much-needed boost in the vendor landscape. TMR also observed that the third important player in the overall market, Clarins, has been winning a significant share as the company has toiled towards introducing a new treatments for body and face over the past few years. A majority of its luxury products by Clarins are centered around pure plant extracts, which has been a clear choice amongst pregnant women.